Rachel Downes, MD

Articles by Rachel Downes, MD

Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GA

ByRachel Downes, MD,Sydney M Crago

June 2nd 2025

Discover how ellipsoid zone integrity predicts geographic atrophy growth rates in recent clinical trials, enhancing future treatment strategies.

Latest Updated Articles

Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GA
Published: June 2nd 2025 | Updated:

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Q&A: Peter Kaiser explains the ongoing SOL-1 and SOL-R study of OTX-TKI

Q&A: Kristina Pfau highlights rare genetic eye conditions

AAO 2025: Don’t miss presentations from our Editorial Advisory Board members

© 2025 MJH Life Sciences^®

All rights reserved.